We measured plasma s(P)RR levels and correlated them with PRA levels (Figure 1) in three groups of prospectively enrolled VMAC patients without CKD (eGFR > 60 mL/min/1.73 m2; n = 16/group) [17]. This evidence concerns the gene S100A6 and chronic kidney disease.